A cancer program's seal of approval
Koering, S.M.
Journal of Ahima 73(1): 40-44
2002
ISSN/ISBN: 1060-5487 PMID: 12469661 Document Number: 551159
Like hospitals and other healthcare organizations, cancer programs are also eligible for accreditation. Here's an overview of how the process works, and how HIM professionals can contribute.
Document emailed within 1 workday
Related Documents
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19Lee, J. 2012: Innovation fast-track? FDA program aims to speed device approval Modern Healthcare 42(16): 12-13
Morrow, T. 2015: A Rare Approval. FDA OKs Pediatric Cancer Drug Managed Care 24(10): 42-43
Anderson, L.F. 1989: Cancer and AIDS groups push for changes in drug approval process Journal of the National Cancer Institute 81(11): 829-831
Beaulieu, A.J. 1993: The IR-4 Project. A national program for the approval of new animal drugs for minor species and minor uses. Accomplishments and goal for minor ruminants Veterinary and Human Toxicology 35 Suppl. 2: 10-11
Printz, C. 2012: FDA's tobacco products research program likely to play role in cancer prevention: Large-scale study, grant funding among program's efforts Cancer 118(12): 2999-3000
Michalek, A.; Mettlin, C.; Cummings, K.M.; Lane, W.; Priore, R. 1983: Use of a population-based cancer registry in evaluating the effectiveness of a cancer screening program Progress in Clinical and Biological Research 121: 177-185
Wallace, M.H.; Bakke, K.; Hubbard, A.; Pendergrass, T.W. 1984: Coping with childhood cancer: an educational program for parents of children with cancer Oncology Nursing Forum 11(4): 30-35
Greenstein, M.; Breitbart, W. 2000: Cancer and the experience of meaning: a group psychotherapy program for people with cancer American Journal of PsychoTherapy 54(4): 486-500
Stone-Wiggins, B.; Porterfield, D. 2001: The North Carolina Cancer Control Program. Caring for uninsured and low-income patients with cancer North Carolina Medical Journal 62(5): 248-251
Zwiebel, J. 2016: The effect on drug development of the National Cancer Institute's Cancer Therapy Evaluation Program Clinical Advances in Hematology and Oncology: H&o 14(3): 157-159
DeShano, C.L. 1996: October is breast cancer awareness month. Physicians aid women through state cancer control program Michigan Medicine 95(10): 40 62
Bonelli, L.; Branca, M.; Ferreri, M.; Barizzone, D.; Rossi, E.; Cedri, S.; Bruzzi, P.; Santi, L. 1996: Attitude of women towards early cancer detection and estimation of the compliance to a screening program for cervix and breast cancer Cancer Detection and Prevention 20(4): 342-352
Kaufman, A.J.; Worrell, J.; Bain, R.S.; Jones, H.W.; Winfield, A.C. 1990: American Cancer Society's Breast Cancer Detection Awareness Program: the 1988 middle Tennessee experience Southern Medical Journal 83(6): 618-620
Akamatsu, N.; Ide, M.; Ueda, Y.; Kondo, Y.; Nakamura, S.; Mori, T.; Ogimoto, I.; Yoshimura, T. 1986: A population survey on mass screening program for gastric cancer part 1. population characteristics related to examination rates for screening program Journal of UOEH 8(2): 177-184
1970: Present state of early diagnosis in bronchial carcinoma. Results of the coordinating program of the German Central Committee for the Fight Against Cancer and Cancer Research Deutsche Medizinische Wochenschrift 95(2): 53-59
Copeland, J.S. 1980: To seal or not to seal? Northwest Dentistry 59(2): 83-86
Pomignoli, M. 1987: The sublingual seal L' Information Dentaire 69(6): 451-459
Tribe, G.W. 1988: Seal virus Veterinary Record 123(16): 426
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910